Immunologic and virologic assessments of anti-retroviral therapy in HIV-infected patients are mainly performed on peripheral blood sample. However, blood represents only 2% of the total lymphocytes in the body. Since the gut-associated lymphoid tissue (GALT) harbors the majority of T lymphocytes i the body. Thus, it is an important reservoir of HIV. Our knowledge of HIV suppression and immune restoration in intestinal mucosa during anti-retroviral therapy of HIV infection is limited. The overall objective of this application is to examine the immunologic and virologic effects of anti-retroviral therapy (PMPA) in GALT in comparison to peripheral lymph nodes and blood of simian immunodeficiency virus (SIV)-infected rhesus macaques, a primate model for AIDS. The applicants will test the hypothesis that the level of CD4+ T cell depletion and the stage of viral infection in T cell repopulation (flowcytometry), viral suppression (bDNA assay, PCR and in situ hybridization) and the emergence of viral genomic diversity and drug-resistant variants in intestinal tissue.
The Specific aim 1 will be to characterize the phenotype of CD4+ T cells repopulating intestinal mucosa of SIV-infected rhesus macaques following anti-retroviral therapy and to determine the mechanisms of the CD4+ T cell repopulation.
The specific aim 2 will be to determine the suppression of viral loads and to examine the emergence of genomic diversity and drug-resistant viral variants in intestinal tissues following anti-retroviral therapy in comparison to peripheral lymph nodes and blood.
The specific aim 3 will be to examine whether T cell activation by short-term IL-2 administration will alter the pool of virally infected cells in GALT of SIV-infected animals that are undergoing PMPA therapy. The applicant believes that the proposed studies will provide insights into the immunologic and virologic effects of anti-retroviral therapy in intestinal lymphoid tissue in comparison to peripheral blood and lymph nodes and that this information will be valuable in development of more effective anti-retroviral and immunomodulatory approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043183-09
Application #
6380667
Study Section
Special Emphasis Panel (ZRG1-AARR-4 (01))
Program Officer
Hamilton, Frank A
Project Start
1992-03-01
Project End
2004-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
9
Fiscal Year
2001
Total Cost
$402,718
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Sena, Angela A S; Glavan, Tiffany; Jiang, Guochun et al. (2016) Divergent Annexin A1 expression in periphery and gut is associated with systemic immune activation and impaired gut immune response during SIV infection. Sci Rep 6:31157
Gaulke, Christopher A; Porter, Matthew; Han, Yan-Hong et al. (2014) Intestinal epithelial barrier disruption through altered mucosal microRNA expression in human immunodeficiency virus and simian immunodeficiency virus infections. J Virol 88:6268-80
Verhoeven, David; George, Michael D; Hu, William et al. (2014) Enhanced innate antiviral gene expression, IFN-?, and cytolytic responses are predictive of mucosal immune recovery during simian immunodeficiency virus infection. J Immunol 192:3308-18
Smith, Phillip D; Shimamura, Masako; Musgrove, Lois C et al. (2014) Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses. J Immunol 193:5604-12
Zaragoza, Melinda M; Sankaran-Walters, Sumathi; Canfield, Don R et al. (2011) Persistence of gut mucosal innate immune defenses by enteric ?-defensin expression in the simian immunodeficiency virus model of AIDS. J Immunol 186:1589-97
Wong, Joseph K; Strain, Matthew C; Porrata, Rodin et al. (2010) In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog 6:e1000748
Smythies, Lesley E; Shen, Ruizhong; Bimczok, Diane et al. (2010) Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem 285:19593-604
George, Michael D; Verhoeven, David; Sankaran, Sumathi et al. (2009) Heightened cytotoxic responses and impaired biogenesis contribute to early pathogenesis in the oral mucosa of simian immunodeficiency virus-infected rhesus macaques. Clin Vaccine Immunol 16:277-81
Raffatellu, Manuela; George, Michael D; Akiyama, Yuko et al. (2009) Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5:476-86
Zhu, He; Stybayeva, Gulnaz; Silangcruz, Jaime et al. (2009) Detecting cytokine release from single T-cells. Anal Chem 81:8150-6

Showing the most recent 10 out of 35 publications